Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$9.14 USD
-0.07 (-0.76%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $9.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
Adherex Technologies Inc. [FENC]
Reports for Purchase
Showing records 1 - 20 ( 102 total )
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for FENC 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Top, Bottom-Line Beat; Nearing Break-Even; 3Q23 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Top and Bottom-Line Miss; 2Q23 Financial Results: Modulating PT to $17
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARQSI Approved in Europe; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARQSI Receives Positive European Opinion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Commercialization on Track; 2022 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Clinical Practice Guidelines Recommend PEDMARK; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK U.S. Launch in Process; Raising PT to $18
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R